At 5.3% CAGR, the Europe Wound Care Market is projected to be worth US$ 6,505.56 million by 2028, says The Business Market Insights    

According to the Business Market Insights’ research, the Europe wound care market was valued at US$ 4,768.03 million in 2022 and is expected to reach US$ 6,505.56 million by 2028, registering a CAGR of 5.3% from 2022 to 2028. Increasing cases of road traffic injuries and rising prevalence of chronic diseases and related wounds are the critical factors attributed to the Europe wound care market expansion.                 

Chronic diseases such as diabetes, cancer, and other autoimmune disorders directly impact the body's natural healing ability. Diabetes and immunodeficiency conditions are among the most detrimental conditions that can slow down the speed of the wound repair process. Diabetes is the most identified chronic disease. Diabetes adversely impacts the immune system, which can complicate wound healing. The hyperglycemic environment promotes the formation of biofilms and makes diabetic wounds difficult to treat. The prolonged healing process due to chronic diseases leads to a long-term need for wound dressings, resulting in high demand for them. Moreover, the increased prevalence of cancer has fueled the number of interventions performed. As a result, wound dressings are often used to prevent postoperative wound infections. Most surgical wounds after cancer surgery are large and deep, resulting in exudate that requires frequent management. Advanced wound dressings such as hydrogels, alginates, and foams help in wound management and infection prevention. As a result, the rise in the prevalence of chronic diseases is propelling the demand for wound care products, fueling the Europe wound care market.

On the contrary, challenges in wound care management and increase in product recalls hurdles the growth of Europe wound care market.   

Based on product, the Europe wound care market is segmented into advanced wound dressing, surgical wound care, traditional wound care, and wound therapy devices. The advanced wound dressing segment held 38.6% market share in 2022, amassing US$ 1,838.08 million. It is projected to garner US$ 2,657.69 million by 2028 to expand at 6.3% CAGR during 2022–2028.     

Based on wound type, the Europe wound care market is bifurcated into chronic wounds and acute wounds. The chronic wounds segment held 61.6% market share in 2022, amassing US$ 2,937.57 million. It is projected to garner US$ 4,070.63 million by 2028 to expand at 5.6% CAGR during 2022–2028.    

Based on end user, the Europe wound care market is segmented into hospitals, specialty clinics, home healthcare, and others. The hospitals segment held 40.1% market share in 2022, amassing US$ 1,910.70 million. It is projected to garner US$ 2,693.57 million by 2028 to expand at 5.9% CAGR during 2022–2028. 

Based on country, the Europe wound care market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 29.9% market share in 2022. It was assessed at US$ 1,423.26 million in 2022 and is likely to hit US$ 2,029.73 million by 2028, exhibiting a CAGR of 6.1% during the forecast period.         

Key players dominating the Europe wound care market are 3M Co, Baxter International Inc, Coloplast AS, ConvaTec Group Plc, Ethicon USA LLC, Integra LifeSciences Holdings Corp, Medtronic Plc, MiMedx, PAUL HARTMANN AG, and Smith & Nephew Plc among others.   

• In May 2021, 3M announced the launch of 3M Prevena Restor BellaForm Therapy – the next generation in post-operative healing following breast surgery.  
• In July 2022, Smith+Nephew announced the launch of the WOUND COMPASS Clinical Support App. The WOUND COMPASS, Clinical Support App, is a comprehensive digital support tool for health care professionals that aids wound assessment and decision-making to help reduce practice variation.  

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com